MIT terminated its subcontract with Nectome after public controversy over the company's fatal brain-preservation claims.
SourceBuilding a way to preserve long-term memories.
Public company, workplace, funding, and market signals
Nectome is a neuroscience/biotechnology startup focused on whole-body, whole-brain post-mortem preservation intended to preserve the connectome and information needed for possible future revival.
Primary product
Whole-body, whole-brain post-mortem preservation service for potential future revival
Founded
2015
Headquarters
Vancouver, Washington, United States
Team size
1-10
Industry
Biotechnology Research
Sub-industry
Brain preservation / neurotechnology
Business model
0 jobs at Nectome
Check back later for new openings
Stage
Seed / venture
Total raised
$275K
Latest round
Seed · Feb 2024
Latest amount
$30K
Leadership
Robert McIntyre
CEO / Co-founder
Co-founder
Chief Scientific Officer
Research Associate
Founder/CEO
Highly research-driven and validation-focused; public posts emphasize independent verification, scientific rigor, transparency, and long-term organizational stability.
Benefits
Pricing
Direct sale of one preservation per contract; public posts say no memberships or insurance, with full-price sales at $250,000.
Differentiators
Technology
Customers
Competitors
Estimated revenue
~$1M ARR (public estimate)
Estimated monthly visits
16.2K
Traffic estimate as of May 2026
MIT terminated its subcontract with Nectome after public controversy over the company's fatal brain-preservation claims.
SourceNectome's Substack · Apr 2026
Discusses long-term care, Oregon operations, for-profit structure, endowment thinking, and legal-risk planning.
New Scientist · Mar 2026
Mainstream coverage of the pig-brain preservation work and Nectome's plans to offer the protocol to terminally ill people in Oregon.
Nectome's Substack · Mar 2026
Details the 12-minute post-mortem window, scheduled MAiD-compatible procedures, and whole-body preservation claims.
Nectome's Substack · Mar 2026
Explains Nectome's direct-sales model, lack of memberships or insurance, and public full-price sales of $250k.
bioRxiv · Mar 2026
Nectome researchers reported near-perfect preservation results in pigs, including a roughly 14-minute perfusability window and connectomically traceable whole brains.